Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis
Authors:
- Delphine SterlinDSDelphine Sterlin
- Martin LarsenMLMartin Larsen
- Jehane FadlallahJFJehane Fadlallah
- Christophe ParizotCPChristophe Parizot
- Marina VignesMVMarina Vignes
- Gaëlle AutaaGAGaëlle Autaa
- Karim DorghamKDKarim Dorgham
- Catherine JusteCJCatherine Juste
- Patricia LepagePLPatricia Lepage
- Jennifer AboabJAJennifer Aboab
- Savine VicartSVSavine Vicart
- Elisabeth MaillartEMElisabeth Maillart
Open Access
- 1 July 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 8 (4)
Abstract
Objective Based on animal models and human studies, there is now strong suspicion that host/microbiota mutualism in the context of gut microbial dysbiosis could influence immunity and multiple sclerosis (MS) evolution. Our goal was to seek evidence of deregulated microbiota-induced systemic immune responses in patients with MS. Methods We investigated gut and systemic commensal-specific antibody responses in healthy controls (n = 32), patients with relapsing-remitting MS (n = 30), and individuals with clinically isolated syndromes (CISs) (n = 15). Gut microbiota composition and diversity were compared between controls and patients by analysis of 16S ribosomal ribonucleic acid (rRNA) sequencing. Autologous microbiota and cultivable bacterial strains were used in bacterial flow cytometry assays to quantify autologous serum IgG and secretory IgA responses to microbiota. IgG-bound bacteria were sorted by flow cytometry and identified using 16S rRNA sequencing. Results We show that commensal-specific gut IgA responses are drastically reduced in patients with severe MS, disease severity being correlated with the IgA-coated fecal microbiota fraction (r = −0.647, p < 0.0001). At the same time, IgA-unbound bacteria elicit qualitatively broad and quantitatively increased serum IgG responses in patients with MS and CIS compared with controls (4.1% and 2.5% vs 1.9%, respectively, p < 0.001). Conclusions Gut and systemic microbiota/immune homeostasis are perturbed in MS. Our results argue that defective IgA responses in MS are linked to a breakdown of systemic tolerance to gut microbiota leading to an enhanced triggering of systemic IgG immunity against gut commensals occurring early in MS.Keywords
This publication has 60 references indexed in Scilit:
- Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporterAnnals of Neurology, 2012
- Crohn's Disease Patients Have More IgG-Binding Fecal Bacteria than ControlsClinical and Vaccine Immunology, 2012
- Beneficial Plasma Exchange Response in Central Nervous System Inflammatory DemyelinationArchives of Neurology, 2011
- The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specificJournal of Clinical Investigation, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphilaFrontiers in Microbiology, 2011
- Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and CancerPhysiological Reviews, 2011
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Molecular Mimicry Revisited: Gut Bacteria and Multiple SclerosisJournal of Clinical Microbiology, 2006
- Rating neurologic impairment in multiple sclerosisNeurology, 1983